Muir-Torre syndrome
Muir-Torre syndrome (pronunciation: myoor-tor-ay sin-drohm) is a rare, autosomal dominant genetic disorder that is characterized by the occurrence of sebaceous gland tumors and/or keratoacanthomas and internal malignancies. The syndrome is named after the two scientists, Dr. Muir and Dr. Torre, who first described it in 1967.
Etymology
The term "Muir-Torre syndrome" is derived from the names of the two scientists, Dr. Muir and Dr. Torre, who first described the condition in 1967. The term "syndrome" is derived from the Greek word "syndromē", which means "concurrence".
Symptoms
The most common symptoms of Muir-Torre syndrome include the development of sebaceous gland tumors, keratoacanthomas, and internal malignancies. These internal malignancies often involve the gastrointestinal tract, genitourinary tract, and breast. Other symptoms may include weight loss, abdominal pain, and blood in the stool.
Diagnosis
The diagnosis of Muir-Torre syndrome is typically made based on the presence of both sebaceous gland tumors or keratoacanthomas and at least one internal malignancy. Genetic testing may also be used to confirm the diagnosis.
Treatment
Treatment for Muir-Torre syndrome typically involves the surgical removal of tumors and the treatment of internal malignancies. This may include chemotherapy, radiation therapy, or other forms of cancer treatment.
Related Terms
- Sebaceous gland
- Keratoacanthoma
- Genetic disorder
- Gastrointestinal tract
- Genitourinary tract
- Breast
- Weight loss
- Abdominal pain
- Blood in the stool
- Chemotherapy
- Radiation therapy
- Cancer treatment
External links
- Medical encyclopedia article on Muir-Torre syndrome
- Wikipedia's article - Muir-Torre syndrome
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski